NOTCH1 and in situ carcinoma: NOTCH-1 activity, which is also altered in MS, is up-regulated by Bacille Calmette-Guérin (BCG), whose protective effects have been reported in individuals with clinically isolated syndromes (CIS) and early MS [31, 32].